Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

10
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
10
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy.

Nature medicine·2026
Same author

<i>PDK4</i> as a metabolic biomarker of chronic hydrocephalus.

Frontiers in genetics·2026
Same author

Predicting surgical outcome in drug-resistant epilepsy by combining interictal biomarkers within a machine learning framework.

Scientific reports·2026
Same author

Predicting Surgical Outcome in Drug-Resistant Epilepsy by Combining Interictal Biomarkers within a Machine Learning Framework.

Research square·2026
Same author

Letter to the Editor. Critical considerations for functional anterior temporal lobectomy adoption.

Journal of neurosurgery·2026
Same author

Correction to: Specialized AI and neurosurgeons in niche expertise: a proof‑of‑concept in neuromodulation with vagus nerve stimulation.

Acta neurochirurgica·2025

Related Experiment Video

Updated: Apr 25, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.4K

VEGF: a potential target for hydrocephalus.

Joon W Shim1, Johanna Sandlund, Joseph R Madsen

  • 1Department of Biology, Indiana University-Purdue University Indianapolis, 723 W. Michigan Street SL354, Indianapolis, IN, 46202, USA.

Cell and Tissue Research
|August 23, 2014
PubMed
Summary
This summary is machine-generated.

Vascular Endothelial Growth Factor (VEGF) may induce enlarged brain ventricles and hydrocephalus. Targeting the VEGF system offers potential non-surgical treatments for hydrocephalus and related neurological disorders.

More Related Videos

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.
08:27

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.

Published on: January 27, 2015

13.5K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

7.7K

Related Experiment Videos

Last Updated: Apr 25, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.4K
Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.
08:27

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.

Published on: January 27, 2015

13.5K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

7.7K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Developmental Biology

Background:

  • Growth factors are crucial for cell development and tissue maintenance.
  • Disrupted growth factor signaling can lead to diseases like cancer and neurological conditions.
  • Enlarged cerebral ventricles and hydrocephalus are linked to altered molecular signaling.

Purpose of the Study:

  • To review the role of biochemical and biophysical factors in communicating hydrocephalus.
  • To investigate the involvement of the VEGF system in hydrocephalus.
  • To explore potential non-surgical therapeutic targets for hydrocephalus.

Main Methods:

  • Review of recent findings on growth factors and hydrocephalus.
  • Analysis of studies implicating VEGF in ventriculomegaly and ependymal alterations.
  • Examination of VEGF secretion sources in pathological conditions.

Main Results:

  • Elevated VEGF levels are observed in pediatric hydrocephalus.
  • VEGF infusion in animals induces ventriculomegaly and ependymal changes.
  • Biochemical and biophysical factors can mimic VEGF effects in hydrocephalus.

Conclusions:

  • The VEGF system is a potential pharmacological target for treating certain types of hydrocephalus.
  • Understanding VEGF secretion sources is crucial for therapeutic development.
  • Preclinical studies suggest molecular targets, including VEGF, for non-surgical hydrocephalus treatment.